HPV and Pap Testing Is Aiding Healthcare Workers to Diagnose Cervical Cancer More Accurately Than Ever

 

Human Papillomavirus (HPV) is a sexually transmitted disease caused by the Human Papilloma Virus (HPV). In men, it is called 'HPV-Infectious Warts' while in women it is called 'HPV-Lymphoma'. The virus has been linked to cervical cancer. HPV and Cervical cancer screening tests are done for the purpose of identification, diagnosis, and prognosis of abnormalities in the cells of the cervix. HPV testing is done through different methods. The most common method of HPV testing is the use of colposcopy or an ultrasound-guided excisional biopsy. This process involves a procedure where a thin endoscope or flexible tube is inserted into the cervix.

A sample of cells is taken from the cervix for examination under the microscope. HPV and Pap testing can also be conducted using co-testing methods. For HPV, genital fluid or cells are tested using a live virus. For the Pap test, a small amount of cervical fluid or cells are used to collect samples for testing. This method can be used to detect tumors in the cervix or endometrium but not in the vagina. However, this method can be used in detecting cancers of the uterine cervix, vaginal endometrium, and cervical cancer.

Many health organizations recommend HPV and Pap testing for all women before they get pregnant. In most cases, the detection of HPV infection can stop the transmission of genital warts during pregnancy. This is the reason why HPV and Pap testing is done during the Pap test in order to screen for cancer. In fact, HPV and Pap testing is the only way to screen for cervical cancer during the pre-pregnancy period. This is because the cervix is only one location on the body where cervical cancer can be detected. Recently, a study in Japan’s Osaka University found that cervical cancer rates can be significantly reduced through preventive measures against the human papillomavirus (HPV) along with proactive cancer testing.